OdysseaBio
De-risking communication from discovery to delivery for biotech, pharma, advocacy, and health decision-makers.
We partner with leadership teams to transform complex science into clear, compelling narratives that reduce risk, build trust, and drive confident decisions at every milestone.
Your Strategic Partner
From discovery through delivery, we ensure your innovation is understood, differentiated, and positioned for maximum impact.
More than translation, we deliver transformation.
“Clear communication isn’t optional; it’s foundational to scientific progress. We support teams at any stage—whether refining existing messaging or building a compelling scientific narrative from the ground up.”
The Value We Bring
-
Anticipate questions, resolve uncertainties, and enter funding and partnership discussions fully prepared.
-
Teams and stakeholders speak with one unified, coherent voice.
-
Decision-makers, clinicians, partners, and investors clearly recognize the rigor and strength of your evidence.
-
Clear, compelling narratives accelerate funding, approvals, and strategic partnerships.
“We’re a small, agile team of two experts who stay directly involved in every project from start to finish. Clients always know who’s shaping their messaging, ensuring clarity, consistency, and confidence at every stage.”
The result is stronger partnerships, smoother development pathways, and confident decisions at every stage.
Meet Our Founders
When you engage with OdysseaBio, you get direct access to two PhD-trained partners who transform science into narratives that reduce risk, build trust, and drive confident decisions.
We value clear science, confident decisions. True partnership, built for alignment. Rigor you can trust. Patients at the core. Precision with flexibility, so your innovation moves faster.
Deborah Maret, PhD
With a research background in glioblastoma spanning preclinical to clinical development, Deborah brings expertise in medical affairs and commercialization, translating complex and real-world data into clear, actionable insights. She has supported biotech startups with strategic scientific narratives and led evidence-based education initiatives, including manuscripts and congress content for diverse clinical audiences.
Georghia Michael, PhD
With a research foundation in preclinical models of arrhythmia and heart failure, Georghia brings deep experience in market access and reimbursement, developing value stories, global value dossiers, and health technology assessment submissions. She transforms advisory insights into actionable medical affairs strategies and aligns scientific communication with clinical and commercial objectives.
From focused strategic reviews to end-to-end narrative development, OdysseaBio adapts to each client’s priorities, timelines, and decision milestones.
Clear Science, Real Impact
-
Clear positioning and differentiated messaging transform complex evidence into competitive advantage, building credibility and stakeholder trust.
-
When teams and stakeholders share a coherent voice and clear strategic direction, decisions move faster, risk is reduced, and commitments follow.
-
Rigorous, persuasive messaging builds trust, demonstrates integrity, strengthens relationships, and positions your innovation for sustainable market leadership.
Well-positioned, evidence-driven strategic communications build credibility and trust, strengthen stakeholder relationships, and establish differentiation that drives market leadership and competitive advantage.